Consequences of counterfeit pharmaceutical product sales
Recently, both the FDA and EMA have raised concerns about counterfeit drug products, including GLP-1s used for weight loss and diabetes, being marketed in the...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Since 1965, we’ve delivered thoughtful, effective advice backed by research and real-world experience.
Stay informed with our latest insights.
Recently, both the FDA and EMA have raised concerns about counterfeit drug products, including GLP-1s used for weight loss and diabetes, being marketed in the...
In this Insights, Tiago Duarte-Silva, Ana Balcárcel, and Keith Czerney discuss how credit rating agencies are adapting their rating methodologies to...
Connect with us at conferences, seminars, and webinars.
Read our case studies to see the problems we’ve solved and results we’ve delivered.